Performance evaluation of implantable cardioverter-defibrillators with SmartShock technology in patients with inherited arrhythmogenic diseases
Martedì 1 marzo 2022
circa 1 minuti di lettura
Journal and Affiliations:
International Journal of Cardiology, 1 marzo 2022
Angelo Auricchio, Cardiologia, Cardiocentro Ticino, Lugano
Tags:
inappropriate shock
inherited arrhythmogenic diseases
SmartShock technology
sudden cardiac arrest
Authors:
Angelo Auricchio